J&J plan to fix quality due at FDA today; Mylan makes $550M deal for Bioniche Pharma;

@FiercePharma: Marching orders for PhRMA's new top exec. Report | Follow @FiercePharma

> Johnson & Johnson (JNJ.N) is expected to outline for U.S. regulators today a strategy to fix quality-control problems that have led to repeated recalls of Tylenol and other consumer medicines since last year. Report

> Generics maker Mylan agreed to buy Ireland-based injectables maker Bioniche Pharma Holdings for $550 million in cash. Article

> Sigma Pharmaceuticals, the target of a takeover by South Africa's Aspen Pharmacare Holdings, cut its full-year profit forecast by as much as 46 percent. News

> The FDA is boosting the boxed warning on rheumatoid arthritis treatment Arava (leflunomide) to highlight the risk of severe liver injury. Release

> Alcon's independent directors' committee emphasized to minority shareholders that Swiss law is on their side in its fight for a higher bid from Novartis. Report

> Gilead Sciences (GILD) sued Lupin in federal court in New Jersey, accusing the Indian generics maker of infringing its patents for Ranexa, an angina treatment. Story

> Peregrine Pharmaceutical's (PPHM) fiscal fourth-quarter loss widened as revenue slumped and the biopharmaceutical company reported higher costs for research and development. Article

> Early treatment for HIV cuts patients' risk of death by about 75 percent, according to a study in the New England Journal of Medicine. Article

> The Bosnian Federation government is likely to postpone the planned IPO of local drugmaker Bosnalijek to after the general elections, to be held Oct. 3. Report

Biotech News

 @FierceBiotech: TheStreet tracks the top 10 clinical trials to watch. Report | Follow @FierceBiotech

 @JohnCFierce: One of the biggest things going on in Alzheimers's right now is Avid's new diagnostic test. This is a game changer. Report | Follow @JohnCFierce

> GSK-backed startup has ambitious plans for immunology. News

> Vivus' Qnexa takes center stage during panel review. Story

> Can Eisai's new Alzheimer's drug fill blockbuster shoes? Report

Manufacturing News

> GSK recovers one of two stolen trailers. Article

> Guide gives template for handling product cross contamination. Report

> Consumers take the offensive against J&J for Tylenol recalls. Item

Vaccine News

> Computer scientist engineers tame type of live vax. Article

> Two new antibodies may lead to HIV/AIDS vaccine. Story

> Bavarian Nordic delivers Imvamune to U.S. News

And Finally... The vast majority of pharma companies now use social media in one form or another, but for most it remains "an enigma," a survey showed. Report | Social media eBook

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.